Combining biocatalytic oxyfunctionalisation and organocatalytic aldol reaction to access chiral β-hydroxy ketones

Journal Article (2024)
Authors

Yutong Wang (Tianjin University, TU Delft - BT/Biocatalysis)

Chiara Domestici (TU Delft - BT/Biocatalysis)

Niklas Teetz (Karlsruhe Institut für Technologie)

Dirk Holtmann (Karlsruhe Institut für Technologie)

Miguel Alcalde (Institute of Catalysis, CSIC, Madrid)

Mengfan Wang (Tianjin University)

Wei Qi (Tianjin University)

Wuyuan Zhang (Chinese Academy of Sciences)

F. Hollmann (TU Delft - BT/Biocatalysis)

Research Group
BT/Biocatalysis
To reference this document use:
https://doi.org/10.1016/j.mcat.2024.114515
More Info
expand_more
Publication Year
2024
Language
English
Research Group
BT/Biocatalysis
Volume number
569
DOI:
https://doi.org/10.1016/j.mcat.2024.114515
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

This study explores a chemoenzymatic cascade to synthesise chiral β-hydroxy ketones by integrating the selective oxyfunctionalisation capabilities of peroxygenases with the carbon-carbon bond-forming progress of organocatalysts. Initial results with simple organocatalysts demonstrated poor performance due to mutual inactivation of the biocatalyst and organocatalyst. However, the use of more complex prolinamide derivatives improved the reaction efficiency and enantioselectivity, enabling a one-pot, one-step synthesis process. This methodology was further optimised to produce high yields of enantiomerically pure aldol products and was shown to be extendable to other substituted toluenes and aldol donors.